Dr Reddys Laboratories Ltd Share Price Today - Live Blog for May 10, 2026

Dr Reddys Laboratories Ltd stock price decreased by -1.05%, with the current market value at 1293.90 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd suffered a -1.05% decline, and it currently trades at 1293.90 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd experienced a -1.05% slump and is currently trading at 1293.90. While the stock maintains a PE ratio of 19.5400, the industry PE is 34.2661, raising questions about valuation.

The stock of Dr Reddys Laboratories Ltd is facing a -1.05% decline and is currently trading at 1293.90 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a -1.05% decrease, Dr Reddys Laboratories Ltd's share price is now 1293.90. Investors should examine the factors driving this decline. The stock's PE ratio is 19.5400, whereas the industry PE ratio stands at 34.2661.

Dr Reddys Laboratories Ltd witnessed a -1.05% decrease in its share price, and it is currently trading at 1293.90. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a -1.05% decrease, reaching a current market price of 1293.90. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd experienced a -1.05% slump and is currently trading at 1293.90. While the stock maintains a PE ratio of 19.5400, the industry PE is 34.2661, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price has fallen by -1.05%, presenting both challenges and opportunities for investors. As of now, it's trading at 1293.90, and market participants are assessing the implications. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd suffered a -1.05% decline, and it currently trades at 1293.90 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd experienced a -1.05% downturn in its share price, and it's currently trading at 1293.90. This situation is generating interest among value investors who are evaluating the stock's potential.